Navigation Links
Sigma-tau HealthScience Launches www.GlycoCarn.com
Date:3/3/2009

- GlycoCarn(R), GPLC (Glycine Propionyl-L-Carnitine) Informational Site -

COMMACK, N.Y., March 3 /PRNewswire/ -- Sigma-tau HealthScience, USA launches www.GlycoCarn.com, an informational website devoted to their revolutionary new L-Carnitine, GlycoCarn(R),USP (Glycine Propionyl-L-Carnitine or GPLC). GlycoCarn(R), "the ultimate nitric oxide and performance enhancing nutraceutical ingredient," has been gaining notice in the athletic, fitness and health world for many benefits continually being uncovered by scientific studies and research teams.

www.GlycoCarn.com breaks down the various areas of fitness and health that GlycoCarn(R) has gained notice in; including cardiovascular health, bodybuilding, endurance, recovery and weight loss. The site explains, in laymen's terms, how the supplement works within the human body, the benefits and applications for use.

Visitors to the site can view the most recent papers from top researchers and scientists with new published studies being posted continually. Press articles, news releases, testimonials from top athletes and information on products that carry the ingredient are of key interest and available for viewing on www.GlycoCarn.com.

www.GlycoCarn.com has proven such a successful endeavor on Sigma-tau HealthScience's part that the site had nearly 3,000 hits in its first 24 hours alone.

Sigma-tau HealthScience, New York, a division of Sigma-tau Health Pharmaceutical, Rome, Italy, is recognized as the world leader in L-Carnitine research, education and manufacturing. GlycoCarn(R) is a member of Sigma-tau HealthScience's AminoCarnitines(R) line of nutraceutical products, the "NOW" generation of L-Carnitine.

For further information on GlycoCarn(R) contact Sigma-tau HealthScience, USA at 180 Varick Street, Suite 1524, New York, NY 10014, Phone (212) 645-5202, Fax (212) 645-0652 or toll free 1-877-246-7468.

    Contact:
    Mollie Tichy
    Creative Image
    631-863-2311/mollie@creativeimage.com


'/>"/>
SOURCE Sigma-tau HealthScience, USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
2. Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries
3. ForteBio Launches New Biosensor for Kinetic Analysis and Screening of Human IgG Antibodies
4. Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada
5. A.L.L. Launches Stop Sebelius Campaign
6. Operation Rescue Launches Opposition to Gov. Sebelius Confirmation as HHS Secretary
7. DaVita Launches Nationwide Events in Honor of National Kidney Month
8. Silverstone Solutions Launches New Version of Kidney Paired Donation Software at DEMO 2009
9. CheckOrphan Launches iWish to Commemorate Rare Disease Day
10. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
11. Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: